Advanced pharmaceutical management for canine storm anxiety uses combination protocols targeting multiple anxiety mechanisms for superior welfare outcomes compared to single-agent approaches.
Advanced storm anxiety pharmaceuticals have transformed the welfare outlook for severely affected dogs whose fear experience was previously managed inadequately with single low-efficacy interventions. The development of Sileo as a species-specific, indication-targeted medication represents a mature welfare pharmacology response to a documented, common, and treatable source of suffering. Combination protocols that address the temporal structure of storm anxiety — anticipatory anxiety building before the storm, peak panic during peak intensity, and recovery afterward — are superior welfare interventions to single acute medications that arrive too late or wear off too soon. Welfare-optimal storm anxiety management is individualized, proactive, and combination-based.